|
Nov 19
|
Ray Dalio’s Latest 13F Portfolio: Top 15 Stocks
|
|
Nov 17
|
Abbott (ABT) Up 5.1% Since Last Earnings Report: Can It Continue?
|
|
Nov 17
|
What's in the Cards for Medtronic (MDT) in Q2 Earnings?
|
|
Nov 17
|
Is DexCom the Next Big Growth Stock?
|
|
Nov 16
|
Doctors, FDA Fight Over Giving Probiotics to Premature Babies
|
|
Nov 16
|
QIAGEN (QGEN) Expands Sample Technologies Line With New Launch
|
|
Nov 16
|
Returns On Capital Are Showing Encouraging Signs At Abbott Laboratories (NYSE:ABT)
|
|
Nov 15
|
Alcon (ALC) Q3 Earnings Miss Estimates, Margins Increase
|
|
Nov 15
|
Abbott (ABT) Just Overtook the 50-Day Moving Average
|
|
Nov 15
|
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Nov 15
|
If You Invested $1000 in Abbott a Decade Ago, This is How Much It'd Be Worth Now
|
|
Nov 14
|
Here's Why You Should Retain Penumbra (PEN) Stock for Now
|
|
Nov 14
|
Bio-Rad (BIO) Hurt by Macroeconomic Woes, Margin Pressure
|
|
Nov 14
|
Charles River (CRL) to Advance AI Drug Discovery With New Pact
|
|
Sep 9
|
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing
|
|
Sep 7
|
Abbott Joins Billion Dollar Roundtable
|
|
Sep 6
|
Abbott (ABT) to Advance Diabetes Care With New Acquisition
|
|
Sep 6
|
Will Weakness in Abbott Laboratories' (NYSE:ABT) Stock Prove Temporary Given Strong Fundamentals?
|
|
Sep 5
|
Abbott (ABT) Dips More Than Broader Markets: What You Should Know
|
|
Sep 5
|
Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes
|